Sintx Technologies

About Sintx Technologies

SINTX Technologies is a leading manufacturer of silicon nitride and other advanced ceramics. Established in 1996, the company focuses on innovating with silicon nitride, a hard, abrasion- and corrosion-resistant material with inherent antibacterial and antiviral properties, and has expanded to other ceramics since 2021. SINTX aims to provide transformative technologies across various industries through high-strength materials for extreme environments.

Products & Services

Silicon Nitride:A very hard, corrosion-resistant ceramic used in biomedical, industrial, and antipathogenic applications, known for high strength and toughness.

Industrial Ceramics (STX-100):High-strength silicon nitride for industrial applications, capable of operating in extreme environments.

Biomedical Ceramics (FleX-SN):Silicon nitride used in spinal implants and prosthetic replacements, with antibacterial and osseointegrative properties.

Antipathogenic Powder (FleX SN-AP):A silicon nitride powder used as an additive or coating to impart antipathogenic properties to medical and non-medical products.

Composite 3D Printing:Support for transforming concepts into quality 3D-printed ceramic parts.

Specialties

Silicon Nitride Biomaterials Antipathogenic Properties Biomedical Applications Industrial Ceramics Composite 3D Printing Aerospace Applications Automotive Applications Energy Applications

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 3800000 MR: - FA: 3.8 million FAN: 3800000	D: 2025-09-08 FD: 2025-09-08	-
2	RT: Private Placement T: - FT: Private Placement	A: 5000000 MR: - FA: approximately $5 million FAN: 5000000	D: 2025-02-25 FD: 2025-02-25	1 investors
3	RT: Equity Public Offering T: - FT: Equity Public Offering	A: 3110000 MR: - FA: $3.11 million FAN: 3110000	D: 2024-09-19 FD: 2024-09-19	-
4	RT: Public Offering T: - FT: Public Offering	A: 1500000 MR: - FA: 1.5 million FAN: 1500000	D: 2024-04-03 FD: 2024-04-03	1 investors
5	RT: Public Offering T: - FT: Public Offering	A: 1300000 MR: - FA: $1.3 million FAN: 1300000	D: 2024-03-25 FD: 2024-03-25	-
6	RT: Public Offering T: - FT: Public Offering	A: 4000000 MR: - FA: approximately $4.0 million FAN: 4000000	D: 2024-02-02 FD: 2024-02-02	-
7	RT: Public Offering T: - FT: Public Offering	A: 4000000 MR: - FA: $4.0 million FAN: 4000000	D: 2024-01-31 FD: 2024-01-31	2 investors
8	RT: Phase II Grant T: - FT: Phase II Grant	A: 1972826 MR: - FA: $1,972,826 FAN: 1972826	D: 2023-10-11 FD: 2023-10-11	1 investors
9	RT: Public Offering T: - FT: Public Offering	A: 12000000 MR: - FA: 12.0 million FAN: 12000000	D: 2023-02-10 FD: 2023-02-10	-
10	RT: Public Offering T: - FT: Public Offering	A: 12000000 MR: - FA: 12.0 million FAN: 12000000	D: 2023-02-07 FD: 2023-02-07	-

Warrant Exercise Latest

2025-09-08

$3.8M

Private Placement 2025-02-25

$5.0M

Equity Public Offering 2024-09-19

$3.1M

View 9 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Eric K. Olson

President, Chief Executive Officer and Chairman of the Board

LinkedIn (Pro only)

R

Ryan Bock

Chief Technology Officer

LinkedIn (Pro only)

G

Gregg R. Honigblum

Chief Investment Officer and Member of the Board

LinkedIn (Pro only)

L

Lisa Marie Del Re

Chief Commercial Officer

H

Hugh Roberts

Managing Director of Business Development

B

Brian Hockett

Senior Vice President of Regulatory and Quality Affairs

View 8 more team members with Pro

Unlock Full Team Directory

Recent News